336
Participants
Start Date
March 31, 2008
Primary Completion Date
December 31, 2008
Study Completion Date
December 31, 2008
U0267
All treatments will be administered topically twice daily (morning and evening) for 8 weeks to areas affected with psoriasis (excluding face and scalp).
Vehicle
All treatments will be administered topically twice daily (morning and evening) for 8 weeks to areas affected with psoriasis (excluding face and scalp).
Mount Sinai School of Medicine, Department of Dermatology, New York
Dermatology Consulting Services, High Point
Florida Academic Dermatology Centers, Miami
FXM Research, Miami
DermResearch, PLLC, Louisville
Minnesota Clinical Study Center, Fridley
Dermatology Treatment & Research Center, Dallas
The Center for Skin Research, Houston
Cherry Creek Research, Inc., Denver
Dermatology Research Center, Inc., Salt Lake City
Therapeutics Clinical Research Center, Inc., San Diego
Oregon Medical Research Center, P.C., Portland
Massachusetts General Hospital Clinical Unit for Research Trials in Skin, Boston
Collaborators (1)
GlaxoSmithKline
INDUSTRY
Stiefel, a GSK Company
INDUSTRY